Inhaled or IV? study tests best way to clear mucus in bronchiectasis
NCT ID NCT07293884
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will compare two methods of giving N-acetylcysteine—a drug that thins mucus—to 70 adults hospitalized with bronchiectasis. Half will receive the drug through a nebulizer (inhaled), and half through an IV. Researchers will measure how well each method reduces sputum thickness, amount, and difficulty coughing it up. The goal is to find which route works better for airway clearance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- N-acetylcysteine
- What this could lead to
- If it works, this could show that one method of giving N-acetylcysteine is better at clearing mucus and making breathing easier for people with bronchiectasis.
- What could go wrong
- This is a small, early-stage study with only 70 people. It may not find a clear difference between the two methods, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHEICTASIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.